Drug & intervention

dextran 70

RxCUI 3274

Clinical trials0
Recruiting0
Related conditions0
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Dextran 70

Dextran 70 is a polymer of glucose produced by bacteria. It is used by injection into a vein to expand blood volume. Specifically it is used for shock such as that caused by bleeding or burns when blood transfusions are not quickly available. However, it does not carry oxygen. It also slows the clotting of blood when injected. It is also used as an eye lubricant and as a carrier for intravenous technetium. Common side effects include vomiting, fever, and joint pains. Other side effects include allergic reactions and poor blood clotting. It is not recommended in people with kidney failure, significant heart failure, or a clotting disorder. It is not recommended during pregnancy. It works by pulling fluid from the extravascular space into the blood vessels. Dextran 70 was approved for medical use in 1947. It is on the World Health Organization's List of Essential Medicines. It comes in either sodium chloride solution or glucose solution.

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Conditions being studied

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.